Virginia Mason Cancer Institute

Seattle, Washington 98111

We've found

1 trials

at this facility

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Status: Enrolling, Phase I, II
Updated: 11/3/2017

from

Seattle, WA

Use our guide to learn which trials are right for you!